Prenetics Global Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Danny Yeung
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 12.9% |
| Management average tenure | 1.8yrs |
| Board average tenure | 1.2yrs |
Recent management updates
Recent updates
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors
Oct 12
Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump
May 29Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues
Apr 08Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%
Jan 07Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M
Sep 09CEO
Danny Yeung (45 yo)
no data
Tenure
Mr. Sheng Wu Yeung, also known as Danny, serves as Co-Founder, Chairperson & Chief Executive Officer at Prenetics Global Limited. He served as Founding Partner at SXE Ventures. Mr. Yeung is a serial entrep...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | no data | 12.94% $ 7.0m | |
| Co-Founder & Chief Scientific Officer | 10.8yrs | no data | 4.4% $ 2.4m | |
| Chief Financial Officer | 6.8yrs | no data | 1.33% $ 718.8k | |
| Chief of Staff to Group CEO & Vice President of People & Operations | 1.8yrs | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Chief Clinical Officer | no data | no data | no data | |
| Chief Consumer Officer & CEO for CircleDNA | 1.4yrs | no data | no data | |
| Chief Executive Officer of ACT Genomics | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
43.5yo
Average Age
Experienced Management: PRE's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | no data | 12.94% $ 7.0m | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | no data | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Independent Director | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data |
1.2yrs
Average Tenure
55yo
Average Age
Experienced Board: PRE's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.